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Biomaterial Design
Eva Barcelona-Estaje, Matthew J. Dalby, Marco Cantini,*
and Manuel Salmeron-Sanchez*
While much work has been done in the design of biomaterials to control
integrin-mediated adhesion, less emphasis has been put on functionalization
of materials with cadherin ligands. Yet, cell–cell contacts in combination with
cell–matrix interactions are key in driving embryonic development, collective
cell migration, epithelial to mesenchymal transition, and cancer metastatic
processes, among others. This review focuses on the incorporation of both
cadherin and integrin ligands in biomaterial design, to promote what is called
the “adhesive crosstalk.” First, the structure and function of cadherins and
their role in eliciting mechanotransductive processes, by themselves or in
combination with integrin mechanosensing, are introduced. Then,
biomaterials that mimic cell–cell interactions, and recent applications to get
insights in fundamental biology and tissue engineering, are critically
discussed.
1. Introduction
Cell–cell adhesions within tissues are largely mediated by cad-
herins, adhesion proteins that play a crucial role in development,
wound healing, and tissue homeostasis.[1,2] This superfamily of
calcium-dependent transmembrane proteins establish homo-
typic interactions with adjacent cells in a zipper-like manner,[3]
forming “adherens junctions” that link these adhesions to the cell
cytoskeleton. Via this linkage, cadherins are able to sense forces
and activate mechanotransductive signaling cascades.[4] While
cadherins are responsible for cell–cell interactions, integrins are
the main transmembrane receptors in charge of the interaction
between cells and their extracellular matrix (ECM). In order to
establish these connections, integrins cluster and recruit other
intracellular proteins, forming focal adhesions. Like cadherins,
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integrins are mechanotransducers: the
properties of the ECM can also be sensed
by the cells and converted into biochem-
ical signals. The combination of these
cadherin- and integrin-mediated processes
allows cells to create a landscape of their
surroundings.
Both types of adhesions activate a myriad
of signaling pathways that control the orga-
nization of the cellular cytoskeleton, signal
transduction, and activation of transcrip-
tional events, which ultimately drive pro-
liferation, differentiation, and migration,
among other cellular processes.[5] Due to
the complex interplay between cell–cell and
cell–ECM adhesions, isolating and study-
ing the signaling pathways in which they
are involved can prove to be a challeng-
ing task. Hence, a range of biomaterials,
with controlled chemical, physical, and geometrical characteris-
tics, have emerged as platforms to study cadherin signaling and
the cadherin–integrin crosstalk. Crucially, while these studies
have contributed to elucidate critical signaling pathways and sig-
nal integration between cadherin- and integrin-mediated adhe-
sion, they have also paved the way to establishing a new paradigm
in biomaterials’ design, where these interactions are harnessed
to control cell behavior, from the control of collective cell migra-
tion, to paracrine secretion and cell differentiation for regenera-
tive medicine applications.
In this review, we first describe the signaling pathways in-
volved in cell–cell adhesion and in the integrin–cadherin adhe-
sive crosstalk, as well as their implications in cell behavior and
fate. Then, biomaterials that have been designed to study cad-
herin or adhesive crosstalk signaling are presented, and the var-
ious approaches that have been proposed to harness the (regen-
erative) potential of these adhesive interactions are discussed.
2. Cadherin Structure and Molecular Interactions
Cadherins are a superfamily of transmembrane receptors which
exist in a wide range of species, from unicellular animals[6] to
mammals, where they are involved in important processes such
as morphogenesis,[7] cell signaling,[8] physical homeostasis,[9]
and mechanotransduction.[10] They can create different kinds
of cell–cell adhesions, such as desmosomes and adherens junc-
tions (AJs). The former are among the strongest cell–cell adhe-
sion types: they can be found in highly mechanically stressed
tissues,[11] where they are arranged on the lateral sides of plasma
Adv. Healthcare Mater. 2021, 10, 2002048 2002048 (1 of 18) © 2021 The Authors. Advanced Healthcare Materials published by Wiley-VCH GmbH
www.advancedsciencenews.com www.advhealthmat.de
Figure 1. a) Cadherin-mediated adhesion without tension. 𝛼-catenin remains closed with the vinculin-adhesion site covered. It can still bind actin.
Vinculin remains in its autoinhibited form. b) When force is applied, 𝛼-catenin opens showing the vinculin-binding site. Vinculin changes its conforma-
tion attaching to 𝛼-catenin and being able to bind F-actin. c) Several proteins are recruited, promoting actin polymerization, myosin contractility, and
subsequent reinforcement of the junction.
membranes and linked to the intermediate filament network.
The latter are the main cell–cell structure that responds to me-
chanical stimuli,[9] being involved in the initiation and stabiliza-
tion of the actin cytoskeleton, in intracellular signaling and tran-
scriptional regulation. They are linked to the cytoskeleton via
the cadherin–𝛽-catenin–𝛼-catenin complex. Other cell–cell adhe-
sions, such as the tight junctions encountered in epithelial cells,
are instead noncadherin-based.[12] In these multiprotein com-
plexes, which prevent the mixing of membrane proteins between
the apical and basolateral membrane and control the passage of
ions between cells, occludins, and claudins are in charge of the
cell–cell adhesion.[13]
The cadherin superfamily shares a common structural com-
ponent named the extracellular cadherin (EC) domain, formed
by ≈110 amino acid residues. Cadherins are classified accord-
ing to the number and arrangements of these domains. The
most studied cadherin families include the classical cadherins,
which create AJs and are expressed in a tissue specific man-
ner: E-cadherin, expressed in epithelia, N-cadherin, in nonep-
ithelial cells, Vascular-Endothelial (VE)-cadherin, in vascular tis-
sues, and P-cadherin, in myoepithelial cells. Such classical cad-
herins comprise a cytoplasmic domain, a transmembrane do-
main, and an extracellular domain (ectodomain) containing five
EC domains. They establish homophilic cell–cell adhesion sta-
bilized by calcium,[14] which serves to rigidify the cadherin ex-
tracellular domains promoting a rod-like conformation that cre-
ates junctional interactions. More precisely, three calcium ions
can bind with different affinities to each one of the pockets be-
tween cadherin extracellular domains, but only two of them ap-
pear to play a role in this rigidification.[15,16] When calcium is de-
pleted, a partial loss of interaction between N-cadherin molecules
has been observed.[17] Simulations also confirm that in the ab-
sence of this ion the interdomain junctions become flexible,
which avoids cis-dimer formation.[16] The most distal domain,
EC1, contains the adhesive sequence in charge of making con-
tact with other cadherins, such as HAVDI for N-cadherin or HAV
for E-cadherin.[18,19] The extracellular cadherin domains are suf-
ficient to create initial contacts even without the intracellular
domain.[20,21] Nevertheless, the cytoplasmatic domain is crucial
for the strengthening of the adhesion, thanks to the actin rear-
rangements near the junction[22] via interaction with catenins.[4]
In 1989, Ozawa et al. discovered that the cytoplasmic region
of E-cadherin was in contact with 𝛽-catenin and p120-catenin.[23]
Subsequent characterization demonstrated that the high level of
sequence identity between classical cadherins was responsible
for the interaction of other cadherins (N- and P-cadherins) with
𝛽-catenin, which binds to 𝛼-catenin.[24] 𝛽-catenin, a highly con-
served protein, present in insects and vertebrates, is also a tran-
scriptional coactivator in the Wnt signaling pathway, crucial dur-
ing embryogenesis and tissue renewal.[25] p120-catenin instead
regulates cadherin levels by controlling cadherin turnover[26] and
also controls small guanosine triphosphate (GTP)ases that regu-
late the actin cytoskeleton[27] (Figure 1a,b).
𝛼-catenin has multiple binding partners, being 𝛽-catenin
and F-actin some of them,[28] and as a consequence, linking
the cadherin/𝛽-catenin complex to the actin cytoskeleton.[29] It
binds to actin filaments and vinculin in a tension-dependent
manner.[30] To be able to bind both 𝛽-catenin and F-actin, this pro-
tein has to experience force-dependent conformational changes.
These changes explain the transition between its weak and strong
bound states with F-actin.[31] Without tension, 𝛼-catenin adopts
an autoinhibited form, in which its vinculin-binding site is
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masked (Figure 1a). On the other hand, when tension is exerted,
force-induced conformational changes uncover the vinculin-
binding site. This strengthens the interaction with vinculin,[32]
which not only makes contact with actin but also stabilizes the
𝛼-catenin open conformation (Figure 1b,c). Once tension stops,
after a sustained force-dependent activation of 𝛼-catenin, it is not
clear if the protein refolds or if it undergoes other cellular pro-
cesses such as proteolysis.[33]
Vinculin is a widely studied mechanosensor not only at AJs,
but also at integrin-mediated adhesions. Its three domains con-
fer vinculin the capacity to bind 𝛼-catenin, 𝛽-catenin, talin, as well
as some regulators of the actin cytoskeleton such as vasodilator-
stimulated phosphoprotein (VASP or Arp2/3 (in the case of the
head domain). The tail can also directly bind F-actin or paxillin
and its own head.[34] Without tension, vinculin is located in the cy-
toplasm in an autoinhibited form, but when there is an increase
in force, it is recruited by the tension-activated 𝛼-catenin,[35–37] re-
inforcing and stabilizing the AJs. Once vinculin is recruited and
activated, it can also bind 𝛽-catenin, allowing the recruitment of
additional vinculin molecules that reinforce the adhesion.[38]
3. Cadherin-Mediated Mechanotransduction
The adhesive connections formed by cadherins are intrinsically
mechanosensitive due to their ability to resist to forces gener-
ated inside the cell (due to the actin cytoskeleton machinery) or
outside it (e.g., due to fluid shear stress or tissue deformation).
Although cadherins by themselves are able to trigger biochemi-
cal signaling events such as the control of organ size or protec-
tion from apoptosis,[39] they can also link cytoskeletons of neigh-
boring cells, creating connections that allow mechanical com-
munication among cells. AJs are the principal cell–cell structure
that reacts to forces and are crucial during embryogenesis, tis-
sue morphogenesis, and for the integrity of adult tissues. AJs
can withstand forces of ≈50–300 pN in vivo[40] and ≈50–100 nN
in vitro;[41] the differences in the magnitude can be due to the
height of the junctions and density of the complexes. As men-
tioned in the previous section, some of the proteins constituting
the AJs, such as vinculin or 𝛼-catenin, are mechanosensitive: they
activate and/or stabilize under tension. Indeed, 𝛼-catenin has
been recognized to be the central molecule in cadherin-mediated
mechanotransduction.[10] 𝛼-catenin unfolds under tensions of ≈5
pN[32] and each cadherin–catenin complex is subjected to a ten-
sion of ≈2–5 pN under resting conditions and ≈50 pN in stressed
conditions.[42] Importantly, the strength of cadherin-based adhe-
sions depends on the local coupling of cadherin clusters to actin
filaments.[43]
Other proteins besides vinculin that bind to 𝛼-catenin and also
play a role in mechanotransduction are formins (mDia1, mDia2,
and formin-1), which are recruited by 𝛼-catenin through the ac-
tivation of RhoA at AJs. Formin recruitment produces the stabi-
lization and organization of the actin cytoskeleton linked to the
junction, giving rise to a reinforcement due to a positive feedback
mechanism for AJ remodeling.[44] Another protein that binds
to 𝛼-catenin and vinculin is 𝛼-actinin, which stabilizes AJs cre-
ating actomyosin-derived tension, thanks to its interaction with
myosin II and vinculin recruitment at AJs.[45] The ajuba mem-
bers (LIM domain-containing protein 1 (LIMD1) and WT1 Inter-
acting Protein (WTIP)) are another family of proteins recruited
by 𝛼-catenin, known to regulate the Hippo pathway, and therefore
the Yes-associated protein (YAP)/WW-domain-containing tran-
scription regulator 1 (WWTR1 or TAZ) mechanical rheostat, by
inhibiting large tumor suppressor kinase 1 (LATS) and allowing
YAP translocation to the nucleus.[46] Finally, Epithelial proteins
lost in neoplasm (EPLINs) work as additional linkers between 𝛼-
catenin and the cytoskeleton although they are not needed for
direct force transmission (Figure 1c).[47]
Mechanosensing via cadherins goes beyond the proteins that
interact with 𝛼-catenin. There are actomyosin remodeling pro-
teins that are recruited and/or activated at AJs in a 𝛼-catenin-
independent manner. Some examples are myosin proteins,
which activate RhoA at the junctions (myosin VI),[48] contribute
to the transmission of forces in nascent AJs (myosin IIB), or
promote tensile forces through the formation of stress fibers
(myosin IIA).[49,50] Others are actin remodeling proteins, such
as VASP, zyxin, and testin (TES), which are recruited to AJs in
a tension-dependent manner.[51] Similar to mechanotransduc-
tive integrin-based adhesions, while AJs are formed by the core
structural and mechanosensitive components described above,
the number of signaling molecules implicated in cadherin-based
mechanotransduction is much greater. Indeed, when actomyosin
remodeling and cytoskeletal dynamics are involved, it is crucial to
consider the role of Rho (RhoA, Rac, and Cdc42) and Rap family
GTPases, which are critical for cadherin-mediated adhesion[52]
and collective migration.[27] More concretely, RhoA, Rac1, and
Cdc42, regulated by p120-catenin, have been demonstrated to be
the key regulators in the assembly, disassembly, remodeling, and
contractility of the actomyosin cytoskeleton. Rac1 and Cdc42 are
in charge of nucleation, polymerization, and stabilization of actin
filaments,[22] while RhoA is involved in actin regulation as well
as myosin contractility through Rho-associated protein kinase
(ROCK).[53] In Chinese hamster ovary (CHO) cells, C-cadherin
adhesion and engagement resulted in increased Rac1 activity
and RhoA inhibition.[54] This increase in the activity of Rac1 was
also observed in epithelial cells, where overexpression of Rac1 or
Cdc42 increased E-cadherin localization, whereas dominant neg-
ative mutants of both Rac1 and Cdc42 inhibited these events.[55,56]
All of these AJ reinforcements, together with actomyosin re-
modeling, provide cells with the necessary information to regu-
late embryo morphogenesis,[57] barrier maintenance,[48] prolifer-
ative control in adult tissue, or collective migration.[58] Also, me-
chanical forces that are sensed via the cell–cell junctions provide
a mode of cell–cell communication that complements better un-
derstood modes of communication such as gap junctions or se-
creted factors.
4. YAP/TAZ
As suggested in the previous sections, the conversion of
cadherin-mediated mechanical stimuli into biochemical signals
plays a crucial role in important cell processes such as tissue
remodeling,[59] collective migration,[60] or cell fate,[61] among oth-
ers. One of the main components of the mechanotransductive
pathways is YAP/TAZ, which is known for its ability to act as a me-
chanical rheostat via its translocation to the nucleus in response
to some mechanical inputs such as cell geometry,[62] stretching,
ECM stiffness,[63] adhesion,[64] and shear stress.[65]
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Figure 2. E-cadherin adhesion showing inhibition of RhoA and activation of Rac1 activity. N-cadherin-mediated adhesion in the cell of the left also shows
the inhibition of YAP translocation to the nucleus due to the activation of MST via Merlin, activation of LATS, and subsequent phosphorylation of YAP/TAZ.
LATS activity is also regulated by AMOT which can bind AJs. FA formation also activates GTPases which inhibit LATS, increasing YAP translocation to the
nucleus. In the cell on the right, inhibition of Rac1 and activation of RhoA by p120-catenin at the cell–cell junction in N-cadherin-mediated adhesions are
shown. On the other hand, integrin-mediated adhesions activate Rac1 at the free end of the cell, provoking actin polymerization and increase in intrinsic
force. The activation of RhoA via integrins can also activate ROCK, increasing myosin activity and producing cadherin disruption. Conversely, activation
of Dia via RhoA stabilizes AJs.
YAP/TAZ is also the central effector of the Hippo signaling
pathway, which negatively regulates the activity of YAP/TAZ by
promoting its cytoplasmic retention by 14-3-3 proteins and sub-
sequent degradation in a mechanical-independent way. YAP re-
cruiting to the cytoplasm is provoked via the LATS, which is acti-
vated by mammalian Ste20-like kinases 1/2 (MST).[66] Although
the signal transduction cascade of the core player kinases of the
Hippo pathway has been intensively studied, the upstream com-
ponents are not well understood.[67] In 2011, Kim et al. demon-
strated that the homophylic interaction among E-cadherins was
one of the direct stimulators of the Hippo pathway via a catenin-
dependent process, which activates Merlin (also known as neu-
rofibromin 2), MST, and finally LATS, leading to phosphorylated
and inactivated YAP (Figure 2, left cell).[68]
The Hippo pathway is also influenced by architectural and me-
chanical cues caused by F-actin and myosin II interactions.[69,70]
Among the essential mediators connecting mechanical stimuli
and Hippo–YAP regulation are Rho GTPases, which are known to
be some of the main effectors in actin remodeling.[66] It has been
demonstrated that RhoA, Cdc42, and Rac1 all enhance YAP activ-
ity, although to a lesser extent in the case of Cdc42 and Rac1.[63,71]
Attachment to other cells via AJs also provokes tension in the
actomyosin cytoskeleton, promoting E-cadherin-dependent YAP
activation and subsequent cell proliferation.[72]
On the other hand, contraction of the actin belts located in the
cytoplasmatic part of the AJs suppresses nuclear translocation of
YAP by the liberation of Merlin from AJs, which exports YAP
from the nuclei.[68,73] It is thought that Merlin provides a reg-
ulated linkage between transmembrane proteins and the actin
cytoskeleton,[74] whose disruption increases Merlin interaction
with LATS, producing YAP phosphorylation and inactivation.[75]
Another actin-binding protein which regulates YAP activity by
both phosphorylating it or sequestering it to the junctions is an-
giomotin (AMOT), which also binds to and interacts with AJ
components.[76] The last actin-dependent kinase involved in the
Hippo pathway is LATS1/2. Some recent studies have shown that
LATS does not play a critical role in actin-dependent mechan-
otransduction because its inhibition does not rescue YAP inhi-
bition by a soft environment.[77] Nevertheless, it has been pro-
posed that LATS activity is sensitive to mechanical cues due to
its activation by protein kinase A (PKA) (downstream of the actin
cytoskeleton).[78]
5. Crosstalk with Extracellular Matrix
Mechanosensing
ECM mechanosensing is mainly conducted by integrins, which
are transmembrane receptors that interact with the ECM via ad-
hesive sequences such as the Arg-Gly-Asp (RGD) motif.[79] In-
tegrins are part of the cell adhesion machinery, which consists
of specialized subcellular contact sites where transmembrane re-
ceptors are in contact both with the ECM and the cytoskeleton.
This machinery creates macromolecular assemblies called focal
adhesions (FAs), through which mechanical and regulatory sig-
nals are transmitted to the cells.[80] For the cells to be able to con-
vert nascent adhesions into FAs, the recruitment of other com-
ponents is required, as this will reinforce integrin–cytoskeleton
bonds.[81–83]
Within FAs, tension is sensed via a change in the conforma-
tion of talin, a protein that links the cytoplasmic tail of integrins
to F-actin. When mechanical force is applied to talin, this protein
changes its conformation exposing a vinculin binding domain,
in such a way that vinculin is translocated to the focal adhesion
producing FA reinforcement.[84] It is also known that when talin
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is activated, F-actin stabilizers and elongators are recruited pro-
voking its polymerization and, as a consequence, cell adhesion
to the ECM and spreading.[85] The molecules described above
belong to the “molecular clutch,” a concept that was proposed
for the first time in 1988 by Mitchison and Kirschner to explain
how the actin retrograde flow exerts tension on a substrate.[86]
For a deeper understanding of the molecular clutch model and
of integrin-mediated mechanotransduction, the reader can refer
to recent reviews.[87–89] Mechanotransduction via integrins also
recruits paxilin and focal adhesion kinases (FAKs); these work
as a scaffold for numerous other proteins that regulate Rho GT-
Pases, promoting stress fiber formation and myosin II activity
though the activation of ROCK, and binding Rho family regula-
tory proteins.[90]
Some of the proteins observed at cell–ECM adhesions are
also present in cell–cell adhesions, creating a converging signal-
ing network called “adhesive crosstalk,” whose regulation is not
fully understood yet. This term is used to highlight crosstalks
between two types of adhesions, based on integrins and cad-
herins in this case, which can interact at different levels. Both
integrins and cadherins are transmembrane receptors, which are
spatiotemporally controlled. Spatially because they both need ac-
tivation through the presence of integrin-adhesion domains or
other cadherins, which is determined by the presence of ECM
or other cells. The temporal regulation comes with the dynamic
processes that involve cadherin and integrin activation such as
changes in protein conformation, cluster formation, or activa-
tion of downstream effectors.[91–93] These receptors also share
signaling molecules, scaffolding and cytoskeletal elements, and
the ability to influence cell growth, survival, and transcriptional
activity.[5]
5.1. Signal Integration
Vinculin binds to talin and 𝛼-catenin in FAs and AJs, respec-
tively, determining the ability of these supramolecular structures
to bear force. In spite of these similarities, vinculin is phospho-
rylated in different sites when it is located in AJs or FAs.[94] In-
terestingly, the degree of phosphorylation also determines force
transmission in both kinds of adhesion.[94,95] Another well stud-
ied component of FAs that also regulates cell–cell adhesion is
FAK: it phosphorylates 𝛽-catenin producing VE-cadherin disso-
ciation in a mechanically independent manner.[96] On the other
hand, when FAK is activated in cells seeded on stiff substrates,
there is an increase in the expression of N-cadherin in mouse
embryonic fibroblasts (MEFs)[97] and vascular smooth muscle
cells (VSMCs), suggesting that FAK can regulate the adhesive
crosstalk in a tension-dependent and -independent way.[91]
One of the main convergence blocks in the adhesive crosstalk
are Rho GTPases, which act upstream and downstream of cad-
herin and integrin interactions. Rho GTPases regulate the assem-
bly of FAs.[98] Similarly, the assembly of AJs is Rho-, Rac1-, and
Cdc42-dependent[99] in a time- and cadherin-dependent way.[100]
Ouyang et al. showed than N-cadherin junctions inhibited Rac1
activity via phosphoinositide 3-kinase (PI3K). To perform these
experiments, MEFs were seeded on fibronectin-coated micropat-
terned strips. They observed that N-cadherin inhibited Rac1 ac-
tivity at the junction through the N-cadherin–p120-catenin axis,
whereas N-cadherin–𝛽-catenin increased myosin II at the junc-
tions. N-cadherin was also found to locally suppress integrins,
creating subcellular polarization. Moreover, they observed Rac1
activation via integrins at the free end of the cells, suggesting in-
tegrin mediation in Rac polarity (Figure 2, right cell).[101] Linked
to these results, it has been seen that p120-catenin can also asso-
ciate with E-cadherin to prevent the activation of integrin func-
tions via Rap1.[102]
New integrin adhesions activate Rho and ROCK, by increas-
ing cell–matrix adhesion, cell shape, and cytoskeletal tension.[103]
These activations play an important role in cell–cell adhesion.
As shown by Playford et al. in 2008, AJ formation can be mod-
ulated by Rho GTPases downstream of integrin signaling. They
found that the inhibition of FAK caused the loss of epithelial
morphology due to an increased activity of RhoA that inhibited
cell–cell contacts.[104] The same effect was observed by Sahai and
Marshall: the activation of ROCK via RhoA promoted the dis-
ruption of cell junctions at AJs. On the other hand, the same
study also observed that Rho signaling through Dia maintains
AJs due to its ability to promote actin polymerization, which re-
stores E-cadherin and 𝛼-catenin localization at the junction (Fig-
ure 2, right cell).[105] It is evident that Rho GTPases are widely
used by the cells as an intracellular communication mechanism
which is influenced by both integrins and cadherins in a spa-
tiotemporally controlled manner.[5]
YAP is also one of the signaling proteins shared by differ-
ent pathways initiated by both integrins and cadherins. The
Hippo pathway keeps YAP in the cytosol. On the other hand,
the mechanosensitive pathway promotes YAP translocation to
the nucleus when cells are located in a stiff environment.
By contrast, if cells are in softer substrates, YAP remains in
the cytoplasm.[63,106] Due to these changes in YAP location in
a mechanical-dependent manner, YAP is named “mechanical
rheostat.”[107] Cosgrove et al. demonstrated that the crosstalk
between integrins and N-cadherins produces changes in the
mechanical state of the cells, leading to a decrease in YAP
translocation to the nucleus when they are located in stiff
environments.[108] Finally, Barry et al. showed that cadherins by
themselves can also be upstream regulators for integrins: me-
chanically stimulated VE-cadherin adhesions led to an increase
in integrin activity.[200] This regulation of integrins by cadherins
was reported also for N-cadherin in zebrafish, where N-cadherins
were observed to stabilize inactive 𝛼5 integrin complexes close to
cell–cell adhesions.[110]
5.2. Effects on Cellular Functions
Signaling through cadherins, integrins, and their crosstalk has
a crucial impact on cellular functions such as morphogenesis,
migration, or differentiation. The process of tissue morpho-
genesis consists of cell assembly into tissues and large-scale
collective movements, which are determined by the different
cadherins and integrins presented within the developing tissues.
During all the stages of development, there is a differential
expression of the various types of cadherins, which act in distinct
developmental contexts.[111] Also, the communication between
integrins and cadherins is regulated in a spatial, temporal, and
tissue-specific way, which is crucial for morphogenesis and
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collective cell migration.[112] For example, during mesenchymal
development, most interactions are cadherin-mediated within
the cell-rich mesenchymal condensate, but, as development
progresses, these interactions are restricted by ECM deposits
secreted by differentiated progenitors that stimulate contact with
the cell microenvironment.[113,114] The communication between
adhesion molecules is bidirectional: cadherin adhesions induce
integrin-dependent fibronectin assembly, which is, for exam-
ple, required for normal morphogenetic movements in early
embryogenesis.[109,115] During morphogenesis, the assembly of
cells in epithelial sheets is essential for compartmentalization in
the body and, at the same time, functionality of the epithelium
is dependent on the polarization of the cells that create it. This
polarization consists of a segregation of the cells into adhesive in-
teractions with the ECM and a nonadhesive part facing a luminal
space.[116] Cadherin role is crucial in polarization and assembly
in epithelial tissues, as shown in several reports.[111,117,118] Also,
the positioning of the apical surface of the epithelial sheets is
controlled by contact of the cell surface with the ECM.[119]
Mechanosensing through integrins and cadherins is necessary
for the assembly and stability of epithelial tissues. It has been
seen that adhesion to ECM proteins, such as fibronectin, stabi-
lizes the epithelial state,[120] but also promotes cell scattering due
to increased RhoA and myosin light chain kinase activity, which
disrupts cadherin-based adhesions.[121] On the other hand, the
stabilization of the epithelial state is produced by a stabilization
of cell–cell adhesion induced by integrins,[122] suggesting that
AJs can respond differently to cytoskeletal tension induced by in-
tegrins: moderate contraction promote AJ stability but stronger
tensions result in a disruption of AJs.[123] Cadherin contacts also
regulate ECM signaling. E-cadherin signaling through Scr and
Rap1 promotes engagement of integrins to a basal ECM,[124] al-
though it locally suppresses integrin adhesion in apical junctions
contributing to polarization.[109]
Cell migration can also be impacted by the adhesive crosstalk.
Indeed, during collective migration, the cells’ cytoskeletons un-
dergo an extensive reorganization, while being coupled between
neighboring cells to allow migration in sheets, strands, and clus-
ters. Three main characteristics define collective cell migration:
physical and functional connection between the cells during
movements, multicellular polarity, which organizes the actin cy-
toskeleton to generate traction and protrusions, and structural
modification of the tissue along the path of the migrating cells.
In order to remain connected, cells create AJs. Moreover, as men-
tioned above, cell–cell and cell–ECM interactions are in charge of
the polarization,[125] which creates “follower” and “leader” cells.
These two kinds of cells have different morphologies which are
mediated by the cytoskeletal organization, controlled by Rho GT-
Pases and myosin II.[126] In epithelial cell migration, the loss of
E-cadherin contacts promotes weakened cell junctions and cell
detachment, provoking a scattering of the cells that will follow
a single-cell mode of migration. This is known as epithelial to
mesenchymal transition (EMT).[127] In EMT, the interaction be-
tween ECM–integrins and neighboring cells is crucial, because
an enhancement in ECM contacts produced by an increase in
ECM stiffness can produce disruption of cell–cell adhesion[121]
and promote cell scattering.[128]
Another major cellular process that can be impacted by the
adhesive crosstalk is cell differentiation. Differentiation is influ-
enced by cell adhesion receptors, ECM composition, cell density,
and cell shape. For example, osteogenesis of human mesenchy-
mal stem cells (hMSCs) on stiff matrices is guided by an interplay
between FAK and RhoA/ROCK signaling, due to the implication
of RhoA/ROCK in cell tension and myosin contractility; this pro-
motes runt-related transcription factor 2 (RUNX2) activity, even-
tually leading to an osteogenic fate.[129] FA formation and matu-
ration are also known to promote osteogenesis.[130] On the other
hand, if the activity of RhoA is modulated, the lineage commit-
ment can be changed: indeed, reducing the activity of this protein
promotes adipogenesis. Osteogenesis has also been found to be
regulated by N-cadherin, although these studies have shown dif-
fering effects. For example, Xu et al. found that N-cadherin nega-
tively regulated MSC osteogenesis due to a negative regulation of
𝛽-catenin and extracellular signal-regulated kinase 1/2 (ERK1/2)
pathways.[131] On the other hand, hyaluronic acid hydrogels func-
tionalized with N-cadherin mimetic peptides were found to en-
hance hMSC osteogenesis.[132]
In the case of chondrogenesis, a dramatic change in cell shape
is observed during early differentiation stages compared to os-
teogenic cells. While in osteogenesis there is a flattening of the
cells due to their interaction with fibronectin in the ECM, in
chondrogenesis (as in adipogenesis) cells remain rounded.[133]
Moreover, YAP has been demonstrated to be a negative regulator
of chondrogenic differentiation.[134] These findings correlate with
the observation that stiff matrices promote an osteogenic pheno-
type, due to the involvement of mechanosensing proteins which
regulate YAP localization, such as FAK or Rho GTPases.[135] On
the other hand, the Hippo pathway influences chondrogenesis,
whereas an overexpression of LATS1 correlates with the mainte-
nance of the chondrogenic phenotype in vitro[136].
6. Biomaterials That Mimic Cell–Cell Interactions
As highlighted in the previous sections, cell–cell adhesion plays
a crucial role in several biological functions. For this reason,
biomaterials have been widely used to study how cells inter-
act with each other via cadherins and how this interaction can
be harnessed for applications in regenerative medicine. The ad-
vantage of using biomaterials is that they can be engineered to
provide signals that recapitulate cell–cell interactions, providing
a platform to gain a deeper understanding of a myriad of cel-
lular processes. Moreover, biomaterials allow to investigate the
synergy between the spatiotemporal presentation of the ligands
and other properties of the environment, such as dimensional-
ity, structural features, or mechanical properties (e.g., mobility or
stiffness).
There are several approaches to promote and investigate cell–
cell interactions via biomaterial design: cadherin-based bioma-
terials make direct use of cadherins (or specific fragments) and
cadherin-adhesion peptides (Table 1), while other approaches
rely on careful design of materials functionalized with ECM
proteins (or peptides) to control cell–cell adhesions. The use of
mimetic peptides has gathered increasing interest due to their
higher stability, easier biomaterial fabrication, and more pre-
cise control over chemical composition compared to the use
of full proteins or protein fragments. Results obtained in vari-
ous studies suggest that both functionalization with cadherins
or with mimetic peptides, by chemically binding them to the
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Table 1. Examples of biomaterials that use cadherin-based constructs.
Cadherin, fragment,
peptide
Material type Cell type Biological effect Ref.
N-cad-Fc Alginate hydrogels MSCs Guided formation of neural networks [139]
N-cad-Fc Polystyrene plates Embryonal carcinoma cells Maintenance of undifferentiated state [140]
E-cad-Fc Antioxidative cell culture dishes MSCs Increase adhesion [141]
E-cad-Fc Glass CHO cells E-cad-mediated actin assembly [142]





Polyacrylamide hydrogels MSCs Paracrine effects [138]
HAVDI Hyaluronic acid hydrogels MSCs Chondrogenic regulation [144]
HAV Peptide nanofibers MSCs Chondrogenic differentiation [145]
HAV Au surfaces Madin-Darby Canine Kidney
(MDCK)
Cell adhesion and clustering [146]
HAVDI Nano- and microporous hydrogels MSCs Paracrine control [147]
Figure 3. Effects of different N-cadherin constructs on MSCs. a) Representative images of YAP/TAZ (green) and DAPI (blue) on hydrogels with the
different N-cadherin constructs. b) Quantification of YAP/TAZ ratios of the conditions showed in (a). c) Secretion of vascular endothelial growth factor
(VEGF) by MSCs seeded on hydrogels functionalized with N-cadherin constructs. Reproduced with permission.[138] Copyright 2020, Elsevier.
material, are able to support cadherin-mediated adhesions, al-
though differences have been observed when comparing the ef-
fects of different cadherin fragments. For example, in the case
of E-cadherin, constructs containing only the first and second
ectodomains were not sufficient to mediate cell adhesion and
spreading in the absence of integrin-based adhesions, allow-
ing only single cadherin–cadherin adhesions without cadherin
clustering.[137] The effect of different N-cadherin constructs has
also been recently studied. Specifically, the whole cadherin ex-
tracellular region, the first two ectodomains, and the HAVDI ad-
hesion peptide were compared in terms of MSC behavior: dif-
ferences in the constructs resulted in different MSC responses
with regard to cell adhesion, YAP/TAZ translocation, paracrine
secretion, and cell differentiation. Although MSCs showed sim-
ilar spreading and traction forces when interacting with the dif-
ferent fragments, the N-cadherin extracellular domain showed
stiffness-dependent changes in nuclear YAP/TAZ (Figure 3a,b),
an increased paracrine secretion (Figure 3c), and myogenic dif-
ferentiation compared to the HAVDI adhesion peptide. All these
differences should be considered when selecting the fragment
used for biomaterial design.[138]
6.1. Biomaterials to Investigate Cell–Cell Adhesion
Due to the difficulty in isolating interactions in native cell–cell
contacts, creating a biomaterial that dissects the effect of cadherin
ligation alone is crucial to understand how cadherin adhesion af-
fects cell behavior.[148] Engineered surfaces have been one of the
first biomaterials used to control and study cell response to cad-
herins.
In 2000, Lambert et al. created a model system to dissect
the molecular mechanisms of cadherin-based adhesion and
subsequent signal transduction to the cytoskeleton. Dimers of
N-cadherin-Fc chimera immobilized on 6.2 µm latex beads were
found to allow calcium-dependent bead–cell binding through
N-cadherins. These experiments revealed that N-cad-coated
beads recruited N-cadherin, 𝛼-, 𝛽-, and p120-catenins at the
bead–cell contact sites, triggering the activation of tyrosine
kinases as well as actin filament redistribution. This study
showed for the first time that cell architecture, contractility,
and microtubule network are essential for cadherin adhesion
(the requirement of linkage to actin filaments was previously
documented[149]). It also proved that N-cadherin ectodomains
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Figure 4. a) Schematic representation of lipid-coated microwells. b) Fluorescently labeled and cadherin-functionalized bilayers imaged after seeding
and after 14 h to test the stability. c) Influence of ligand mobility on cell behavior. Adapted with permission.[152] Copyright 2011, The Royal Society of
Chemistry. d) MDCK adhesion at 6 h of cells seeded on RGD/HAV (RH) surfaces and RGD/SCR (RS) surfaces before and after the addition of free HAV
or SCR peptides [(s) stands for soluble]. e) Images of cells stained for vinculin, showing the difference in FA. f) Area of MDCK cells cultured in the
different conditions for 6 h. Adapted with permission.[146] Copyright 2019, Wiley-VCH GmbH.
are sufficient to mimic cadherin-mediated cell contact and signal
transduction.[150] Similarly, Kovacs et al. coated glass surfaces
with E-cad-Fc to determine the relationship between cadherin
binding and cytoskeletal activity during early cadherin adhesive
contacts: they observed that the homophilic ligation between the
cadherin chimera and cellular E-cadherin activated the Arp2/3
complex, producing actin nucleation at the junction.[142]
To fully understand how cells respond to cadherin-mediated
adhesions, it is however necessary to develop biomaterials that
present cadherins in a way that resembles how they are presented
by the cells themselves. As previously described, cadherins are
transmembrane proteins and hence are laterally mobile due to
the viscous nature of the cell membrane. Biomaterials can be
engineered to present controlled substrate mobility, allowing to
study how this physical property affects cadherin-mediated ad-
hesion. To achieve this, Tsai and Kam used lipid bilayers. Silica
beads of 5 µm diameter were functionalized with the extracellular
recognition domains of E-cadherin, either by directly adsorbing
the fragments onto the beads’ surface, or by attaching the cad-
herin to a lipid bilayer, resulting in a laterally immobile or mobile
presentation of the cadherin. Lateral mobility of the E-cadherin
was found to increase its recognition at lower concentrations, by
promoting Rac1 activity. These results proved the mechanosen-
sitivity of cadherin-mediated adhesions, and demonstrated the
need of a proper biomaterial design when using cadherins.[151]
Andreasson-Ochsner et al. added another cue, dimensionality,
enabling a more physiological-like 3D interaction of the cells with
the cadherins. Specifically, they developed a 10 µm deep microw-
ell platform that presented a cell membrane mimetic interface
made of supported lipid bilayers with tunable lateral mobility,
functionalized with E-cad-Fc. CHO cells seeded on microwells
with high cadherin lateral mobility showed a more diffuse actin
organization and a better adaptation to the shape of the microw-
ell due to their inability to apply forces (Figure 4a–c).[152] Ge et al.
also mimicked the cell surface by developing polymer-tethered
lipid multi-bilayer stacks functionalized with N-cadherin linkers.
In this system, another physical cue, stiffness, can be modulated
depending on the number of stacked bilayers, and the dynamic
assembly and disassembly of cadherin linkers into clusters nor-
mally observed at cell–cell interfaces can be replicated. Changes
in cytoskeleton organization, AJ formation, and cellular traction
forces were observed as consequence of bilayer stacking, demon-
strating the role of stiffness in cell–cell adhesion.[153]
Another platform that has been used to understand cell
response to cadherin-mediated adhesion are hydrogels, poly-
meric materials that have a distinct 3D structure, tunable
mechanical properties, and can be easily functionalized; these
characteristics make hydrogels suitable platforms to study the
interplay between cadherin engagement and a variety of struc-
tural or physical cues. An example of hydrogels that modulate
cell–cell adhesions without direct cadherin functionalization
was showed by Wang et al. In their study, polyethylene gly-
col diacrylate (PEGDA)-based hydrogels functionalized with
gelatin or matrigel were used to investigate how stiffness affects
cellular heterogeneity during proliferation from single cells
to multicellular populations. Epithelial cells located on soft
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substrates (1.2 kPa) had stronger E-cadherin expression and
more E-cadherin/𝛽-catenin membrane localization compared to
cells seeded on rigid coverslips. This study demonstrated that
substrate stiffness regulates epithelial cellular heterogeneity by
modulating E-cadherin/𝛽-catenin mechanotransduction.[154]
6.2. Biomaterials to Investigate the Effects of the Adhesive
Crosstalk
As elucidated in Section 5, cell adhesion occurs both via cell–cell
and cell–ECM interactions. These two types of adhesions are con-
nected to each other via the adhesive crosstalk, which regulates a
wide range of cellular functions.
Li et al. used biomaterials to study the role of the adhe-
sive crosstalk in the adhesion and clustering of epithelial cells.
To investigate cell response to cell–cell and cell–ECM adhe-
sions, MDCK cells were seeded on gold surfaces functional-
ized with different adhesion peptides: HAV (for E-cadherins)
and RGD (for integrins), or a scrambled (SCR) cadherin con-
trol and RGD. Surfaces were functionalized in a 1:400 RGD to
HAV/scrambled peptides ratio in order to allow enough adhesion
without masking HAV-induced interactions. Cells were found to
be more spread and to develop more mature FAs when seeded
on RGD/HAV surfaces compared to RGD/scrambled surfaces.
Addition of free HAV peptide in the culture medium dramati-
cally decreased cell area, making it comparable to the cells seeded
on RGD/scrambled surfaces. The reduction in the cell area was
explained by the interaction of free HAV with E-cadherin on
the cell membrane, decreasing E-cadherin participation in cell
adhesion to the substrate. Conversely, adding free HAV to the
RGD/scrambled surfaces did not change cell area (Figure 4d–f).
This confirmed the cooperation of immobilized HAV–E-cadherin
interaction with the integrin adhesion. The fact that only immo-
bilized HAV was able to generate cell spreading demonstrated
that HAV-induced cell adhesion was related to mechanosensing
and to the ability to generate force. Indeed, the use of a contractil-
ity inhibitor, blebbistatin, abrogated cell spreading on RGD/HAV
surfaces, while it did not have any effect on cells seeded on
RGD/scrambled surfaces. Moreover, cell clusters were weaker on
RGD/HAV surfaces due to a shift from cell–cell interactions to
cell–substrate interactions.[146]
Biomaterials have been also used to investigate the influence
of the mechanical properties of the substrate and of the spa-
tial organization of the receptors in the adhesive crosstalk. Poly-
dimethylsiloxane (PDMS) substrates with different stiffnesses
(5 and 60 kPa) were patterned with islands of fibronectin sur-
rounded by E-cad-Fc. These substrates supported the formation
of FAs when the stiffness was high, while both FAs and cadherin-
mediated adhesions were observed when the stiffness decreased,
showing an inhibition of cell–cell mimetic contacts on more rigid
substrates.[155] Stiffness also modulates intercellular force trans-
duction mediated by VE-cadherins in endothelial monolayers,
as shown by Andresen Eguiluz et al.[156] Using polyacrylamide
gels (1.1 and 40 kPa) functionalized with fibronectin, the au-
thors observed that VE-cadherin-mediated cell stiffening in the
monolayer was dependent on substrate stiffness. Specifically, VE-
cadherins were mechanically stimulated via magnetic twisting
cytometry to activate cell stiffening, showing higher relative stiff-
ening in soft substrates compared to stiff hydrogels and glass.
This could be explained by the lower basal stress in soft gels,
which offers a wider range of mechanical response. Moreover,
the mechanical perturbation of VE-cadherins caused a decrease
of cell contact area between cells on glass, and a higher increase
in the gap area on stiffer matrices. Interestingly, force loading
in VE-cadherin triggered cell–matrix junction remodeling by in-
creasing the size and number of FAs only in stiff substrates and
glass. These results show that although integrins were activated
by intracellular signals, FA response and overall stiffening de-
pend on outside mechanosensing,[156] as observed in E-cadherin
force transduction in single cells.[157] Ultimately, this study shows
that substrate stiffness modulates force-activated endothelial dis-
ruption, suggesting that ECM stiffening, for example, due to age,
can contribute to endothelial junction destabilization.[156] Lampi
et al. also studied the influence of matrix stiffness on endothe-
lial monolayers by using methacrylated hyaluronic acid hydro-
gels functionalized with RGD and photopatterned to create both
soft and stiff microregions. While cells grew preferentially on stiff
matrix regions during monolayer formation, VE-cadherin stain-
ing revealed disruption in cell–cell junctions and intercellular
gaps located at stiffness interfaces, providing evidence that stiff-
ness heterogeneity compromises the integrity of an endothelial
monolayer.[158]
Mechanotransduction via integrins has also effects on N-
cadherins. Indeed, N-cadherin expression was found to be stimu-
lated by ECM stiffness in VSMCs and MEFs. Higher matrix stiff-
nesses induced cell stiffening via Rho GTPases and subsequent
activation of N-cadherin. In fact, when Rac1 activity was inhib-
ited, N-cadherin expression was reduced. Upstream of Rac, FAK
was found to be responsible for N-cadherin expression, connect-
ing cell–ECM to cell–cell adhesion. Interestingly, N-cadherin was
found to be an essential effector in cell cycling, both in vitro and
in vivo, leading to cell proliferation. This mechanism is used by
VSMCs, as the tissue stiffness increases in response to vascular
injury. This was demonstrated by Mui et al., who showed that
when cell spreading is limited, N-cadherin mediates cell prolifer-
ation via the FAK–p130Cas–Rac pathway.[97] Although cadherins
have been known to inhibit cell proliferation,[159] these data, to-
gether with other reports,[160] suggest that the proliferative ca-
pacity of cadherins can be modulated by the environment. An-
other study was presented by Cosgrove et al., who seeded MSCs
on hyaluronic acid hydrogels with varying stiffnesses. These gels
were functionalized with constant concentrations of RGD and
varying amounts of HAVDI. Results showed that N-cadherin lig-
ation reduced the mechanical state of the cell and consequently
YAP/TAZ translocation to the nuclei, resulting in an altered inter-
pretation of ECM stiffness. In this case, HAVDI ligation inhibited
Rac1, which is in charge of the accumulation of myosin IIA in
FAs, inhibiting their maturation and growth. This mechanobio-
logical mechanism shows that the ligands presented to MSCs can
alter the mechanosensing of the environment and, ultimately,
cell fate[108].
6.3. Applications of Cadherin-Modified Biomaterials
Biomaterials are not only used to study biological paradigms; due
to their unique chemical and physical characteristics, they have
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Figure 5. Effect of cadherin mimetic peptides in paracrine secretion. a–c) Schemes representing cells on tissue culture plates (a), nanoporous hydro-
gels (referred to as hydrogels) (b), and microporous hydrogels (referred to as scaffolds) (c). d) Heatmap showing the secretion profile of hMSCs on
the different surfaces. e) Effects of conditioned media (CM) on myoblast migration with and without N-cadherin inhibition.[163] f) CM from HAVDI-
functionalized hydrogels stimulated myoblast migration even at low doses, while the maximum dose was needed for scram hydrogels. g) Migration
velocity and h) migrated distance increased in HAVDI–CM stimulated myoblasts, while no change was observed in scram–CM stimulated myoblasts. i)
Effects of N-cadherin blocking of MSCs cultured in HAVDI or scram hydrogels.[147] Reproduced with permission.[147,163] Copyright 2017, 2019, Elsevier.
been widely used for specific applications in tissue engineering,
such as controlling paracrine secretion, stemness maintenance,
or cell differentiation.
For example, biomaterials have been designed to enhance
paracrine signaling. This is highly relevant in tissue engineering
due to the various biological processes that can be influenced,
such as cell migration, or differentiation.[161,162] Indeed, the mi-
crostructure of hydrogels can be engineered to passively promote
cell–cell interactions: microporous hydrogels promoted cell clus-
tering, sensitizing hMSCs to growth factors and in turn affect-
ing paracrine secretion activity. To prove that these effects were
caused by N-cadherin-mediated adhesion, cells were seeded in
tissue culture plates and encapsulated in nanoporous (10 nm)
and microporous (125 µm) gels that inhibited and promoted
cell–cell contacts, respectively (Figure 5a–c). The paracrine activ-
ity of cells seeded in nanoporous gels remained the same com-
pared with cells seeded on a tissue culture plate. Nevertheless,
when cells were seeded in the microporous scaffolds, a higher
secretory profile was observed (Figure 5d). Indeed, when cell–
cell contacts were inhibited by a blocking antibody, downregula-
tion in the secretion of all cytokines produced by MSCs seeded
in microporous gels was observed. The effects of the MSCs–
conditioned media (CM) were tested on myoblast behavior, show-
ing enhanced myoblast migration in microporous gels, an effect
that was abrogated by N-cadherin blocking (Figure 5e).[163] The
same group further clarified the role of N-cadherin in paracrine
secretion by functionalizing their nanoporous gels with HAVDI.
In this case, MSCs showed higher paracrine activity compared to
MSCs seeded in hydrogels functionalized with a scrambled pep-
tide (scram hydrogel) (Figure 5f–i).[147] This HAVDI-mediated en-
hanced effect is presented as a solution to the lower cytokine se-
cretion in nanoporous hydrogels. Other studies confirmed the
importance of cell–cell contacts in stem cell secretory character-
istics. For example, distinct porous environments formed by mi-
crogels with different diameters were created to investigate their
influence in hMSC clustering and paracrine secretion. Consis-
tent with the previously described study, microgels that allowed
cell clustering showed higher MSC secretion. Moreover, if the hy-
drogels were functionalized with HAVDI, secretion was observed
to increase even in the nanoporous hydrogels, demonstrating the
importance of N-cadherin in paracrine function,[164] and the cru-
cial role of the cell–cell interactions in guiding cell response.
Another area in which cadherin-functionalized biomaterials
have been useful is the expansion of pluripotent stem cells
(PSCs), due to their potential in regenerative medicine and cell
therapy. These cells require expansion in cell colonies to main-
tain cell–cell contacts and retain their pluripotency, nevertheless
this expansion method limits scalability and without E-cadherin
adhesion, apoptosis occurs. To solve these issues, alginate hy-
drogels functionalized with E-cadherin-mimicking peptides have
been used by Richardson et al. Several E-cadherin adhesion pep-
tides were employed (HAV10, Ala-Asp-Tyr (ADT) 10, HAV6, and
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Figure 6. Cadherin-functionalized hydrogel effects on chondrogenesis. a) Scheme of the system developed by Li et al. b) Expression of SOX9 and c)
aggrecan in hMSCs seeded in hydrogels without functionalization (KLD) or functionalized with HAVDI or scram peptide and nonchondrogenic group
(GM). d) 𝛽-catenin localization in the different hydrogels. Reproduced with permission.[167] Copyright 2017, Elsevier. e) Effect of HAV concentration in
MSC expression of chondrogenic markers; the numbers next to HAV makes reference to the percentage of HAV peptides to the total number of peptides
in the hydrogel (HAV + scrambled). f) Effect of the presence of transient HAV (tHAV) in the expression of collagen II (COL2). g) Effect of A Disintegrin
and metalloproteinase domain-containing protein 10(ADAM10) inhibition in the expression of COL2. Adapted with permission.[144] Copyright 2018,
Wiley-VCH GmbH.
ADT6), based on the active domains of the bulge (ADT) and
groove (HAV) regions of E-cadherin. Short and long variants (6 vs
10 amino acids) were used due to the influence of the length of
the peptide on cell adhesion. All these peptides supported PSC
adhesion, pluripotency maintenance, and differentiation poten-
tial, with HAV10 and ADT10 being more effective, probably due
to their longer amino acid chain. This study highlights the impor-
tance of E-cadherin adhesion in PSC expansion and shows how
adhesion peptides can be useful in regenerative medicine.[165]
Cadherin-functionalized materials have also been used to
guide cell fate. In this context, E-cadherin-coated poly(lactic-co-
glycolic acid) (PLGA) microparticles induced hepatic differen-
tiation of hMSCs in hMSC/E-cad–PLGA cellular aggregates. A
1:3 ratio of E-cad–PLGA to hMSCs was found to enhance the
expression of hepatic-specific markers and achieve hepatic dif-
ferentiation of MSCs after 4 weeks.[166] N-cadherin or its adhe-
sion peptides have instead been widely used in biomaterial de-
sign for their chondrogenic potential. For example, Li et al. in
2017 developed self-assembled N-cadherin mimetic peptide hy-
drogels that promoted chondrogenesis. To create these hydro-
gels, HAVDI was combined with the self-assembling peptide
KLD-12 (Figure 6a). hMSCs encapsulated in the resulting gels
had higher expression of chondrogenic markers such as SRY-Box
Transcription Factor 9 (SOX9) or aggrecan (Figure 6b,c) as well
as higher matrix deposition compared to nonfunctionalized or
scrambled hydrogels. Further analysis revealed that N-cadherin
adhesion promotes chondrogenesis by upregulating the expres-
sion of glycogen synthase kinase 3 beta (GSK-3𝛽), which in-
creases 𝛽-catenin degradation (Figure 6d). The degradation of 𝛽-
catenin reduces its translocation to the nucleus, inhibiting the
Wnt/𝛽-catenin signaling pathway.[167] This pathway is considered
to be a major modulator in osteogenesis and chondrogenesis via
the translocation of 𝛽-catenin to the nucleus, enhancing osteoge-
nesis via RUNX2 upregulation[168] and suppressing chondrogen-
esis via SOX9 downregulation.[169] Aggrecanase-degradable PEG-
based multiacrylate gels functionalized with HAVDI were also
used to induce chondrogenesis; they promoted cell–cell interac-
tions in hMSCs and osteochondral repair after being implanted
in rabbits for 18 weeks.[170] The efficacy of HAV-functionalized
hydrogels in vivo has been also explored using injectable ther-
mosensitive 3D hydrogels. These scaffolds benefit from host–
guest interactions between 𝛽-cyclodextrin, linked to a thermosen-
sitive hydrogel, and adamantane, which was functionalized with
transforming growth factor beta 1 (TGF-𝛽1) and HAV. The ther-
mosensitivity of the hydrogel allows its injection in a sol state
and its gelation at 37 °C. The gels were injected into pockets of
living animals, producing chondrogenesis.[171] In another study,
N-cadherin stimulation to promote chondrogenesis was achieved
by functionalizing alginate hydrogels with a peptide derived from
the low-density lipoprotein-receptor-related protein 5, which also
binds N-cadherin.[172] Finally, Cimenci et al. proposed a peptide
hydrogel made of nanofibers with HAV residues. The fibers pro-
moted viability and cell adhesion and enhanced the expression of
cartilage matrix components.[145]
How cadherin adhesion peptides are temporally presented also
influences chondrogenic differentiation. This effect was studied
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using hyaluronic acid hydrogels that encapsulate MSCs: the gels
were functionalized either with HAV adhesion peptides in differ-
ent doses (referred to as “HAV” conditions) or with an ADAM10-
cleavable domain between the hydrogel and the different doses of
HAV (referred to as “tHAV” conditions). Endogenous ADAM10
on the MSCs cleaved the peptides, reducing HAV presentation
within the gels in a time-dependent fashion. Stable HAV presen-
tation enhanced chondrogenesis in a dose-dependent manner,
in such a way that chondrogenic markers were the greatest for
higher concentrations of HAV (Figure 6e). Conversely, transient
presentation via addition of the ADAM10-cleavable domain ab-
rogated the increase in chondrogenesis markers and matrix pro-
duction (Figure 6f). ADAM10 inhibition enhanced again MSC
differentiation (Figure 6g)[144] by stabilizing HAV, revealing the
importance of time and dose presentation of HAVDI in chon-
drogenic differentiation. All these material platforms prove the
ability of biomaterials that stimulate stable N-cadherin-mediated
adhesion and signaling in guiding cell fate toward chondrogene-
sis, providing exciting solutions for cartilage repair.
Hydrogels functionalized with N-cadherin peptides have also
been used for osteogenic differentiation. Hyaluronic acid hydro-
gels functionalized with RGD and HAVDI promoted osteoge-
nesis by mimicking the pro-osteogenic niche in the endosteal
space.[132] It is known that N-cadherin promotes osteogenesis
in early stages of differentiation,[173] while maintained presenta-
tion inhibits the canonical Wnt/𝛽-catenin, inhibiting mature os-
teoblast formation.[168] It is thought that due to the low seeding
density and slow proliferation of hMSCs seeded on hyaluronic
acid gels, N-cadherin contact is limited, promoting osteogenic
differentiation. Also, the N-cadherin adhesion peptide interac-
tion with osteoblasts recreated the pro-osteogenic niche environ-
ment, contributing to hMSC osteogenesis. As this hydrogel de-
graded over time, overinteraction with N-cadherin did not oc-
cur. Interestingly, addition of free HAVDI to the gel reduced the
osteogenic activity, due to its antagonistic effect with the teth-
ered peptide. These gels were also functionalized with RGD,
whose interaction with integrins is also important for osteogenic
differentiation.[174] For this reason, the implication of N-cadherin
alone in osteogenic differentiation cannot be concluded.[132] An-
other study showing the effects of N-cadherin in periosteal cell
differentiation was presented by Evans et al., who used lipid bi-
layers functionalized with the receptor. Their work proved the
relevance of N-cadherin presentation in short-term cell behav-
ior. Indeed, it was seen that N-cadherin on lipid bilayers pro-
moted cell aggregation; on the other hand, cells on bilayers with-
out N-cadherin remained nonadherent but with increased N-
cadherin transcription and zonula occludens-1 (ZO-1) (a tight
junction membrane protein) expression. These platforms placed
periosteal cells in distinct cellular contexts, which guide the emer-
gence of tissue architecture.[175]
N-cadherin signaling has another important role in neural
regeneration. PEG hydrogels functionalized with a gradient of
HAVDI peptides were used in the neural differentiation of
murine embryonic stem cells. Cells showed a loss of pluripo-
tency at higher concentrations of HAVDI, with an increase in
neurite extension length, although the percentage of polarized
cells remained unaffected. However, the highest concentration
of N-cadherin adhesion peptide (537 × 10−6 m) also increased
apoptotic markers.[176] The same material was used to study
the effect of HAVDI gradients on the neural differentiation of
induced pluripotent stem cells, showing similar concentration-
dependent effects on survival, neurite extension, and neural
differentiation.[177]
Finally, VE-cadherin-functionalized biomaterials have been
used to guide hMSCs toward endothelial differentiation. Gao
et al. used a polyamidoamine/thiolated hyaluronic acid injectable
hydrogel functionalized with hVE-cad-Fc to promote adhesion,
proliferation, and upregulation of the expression of endogenous
VE-cadherin and secretion of growth factors in hMSCs. These
effects were achieved due to an overexpression of VE-cadherin
compared to nonfunctionalized hydrogels, which led to secre-
tion of proangiogenic-related factors. Moreover, the activation of
mechanotransductive VE-cadherin signaling pathways led to the
phosphorylation of FAK and to the cytoplasmatic sequestration
of YAP;[178] previous studies have showed that phosphorylated
YAP is able to bind to 𝛼-catenin and induce angiogenic activa-
tion in endothelial cells.[179] With the same aim of promoting
endothelial differentiation, Nie et al. created a chitosan hydrogel
that instead of using direct VE-cadherin contacts, promoted its
expression via nitric oxide (NO) release. The NO released from
the hydrogel upregulated early endothelial cells markers and VE-
cadherin expression in mouse embryonic stem cells.[180] These
two platforms show different approaches to endothelial differen-
tiation without the use of exogenous growth factors, representing
a safe cell therapy source for vascular diseases.
Another emerging field of research that could take advantage
of cadherin-based biomaterials is organoid engineering. Indeed,
due to the importance of cell–cell adhesion in development and
multicellular tissues, controlled cadherin engagement is crucial
in the design of organoid systems. This engagement can be reg-
ulated either by designing the structural, adhesive, and degra-
dation properties of the organoid matrix to permit cadherin-
mediated adhesions or by introducing synthetic cadherin inter-
actions, as the ones reviewed in this Section 6.[181] While many
organoid systems are still based on matrigel, which provides a
less controlled and chemically undefined environment, the use
of ad hoc functionalized materials could better promote the for-
mation and maturation of the organoids. Nevertheless, this is a
still emerging field, and most of the research on organoids sup-
ported by engineered materials is still focused on using cell–ECM
binding ligands.[182–184]
6.4. Applications of the Adhesive Crosstalk in Biomaterial Design
As mentioned in Section 5.2, one of the cellular functions con-
trolled by the adhesive crosstalk is collective migration. Several
biomaterials have been designed to fully understand and repli-
cate this fundamental biological process. For example, Borghi
et al. in 2010 investigated the role of the spatial organization
of integrin- and cadherin-based adhesions during migration by
seeding individual cells on micropatterned polyacrylamide sur-
faces functionalized with collagen IV and E-cadherin in alternat-
ing stripes. FAs were created only in collagen areas and cell mi-
gration only occurred if collagen was present; purely E-cadherin-
functionalized surfaces instead did not support migration. More-
over, an increase in the concentration of E-cadherin in the com-
bined surfaces did not affect the migration rate. Cell migration
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Figure 7. a) Scheme of the hydrogels designed by Carrion et al. b,c) Expression of N-cadherin (b) and collagen II (c) in MSCs seeded on hydrogels with
different chemicals (RGD, hyaluronic acid, and/or collagen) and mechanical (5% and 10% PEG) properties. Adapted with permission.[187] Copyright
2016, Wiley-VCH GmbH. d) Image of the peptide gradients in combinatorial hyaluronic acid gels. Differential expression of e) SOX9 (blue) and f)
aggrecan (purple) in the combinatorial gels. g) Hydrogels with specific chondro (+) and chondro (−) formulations. h) Expression of chondrogenic
markers in hMSCs seeded in chondro (+) or chondro (−). Reproduced under the terms of the CC-BY 4.0 International License.[188] Copyright 2018, the
Authors. Published by Springer Nature.
was found to be influenced by the direction of the stripes, due to
the distribution of traction forces where FAs were created. Since
E-cadherin-mediated adhesion controlled the location of FAs by
allowing their formation only on ECM-coated regions, cell–cell
adhesion emerged as a tool to control migration directionality.[185]
The same group then created a minimal tissue mimic platform
that simulates the 3D interactions that the cells experiment in
the process of wound healing, introducing dimensionality in the
material platform. This interface consisted of a basal ECM sur-
face functionalized with ECM proteins and an orthogonal wall
functionalized with E-cadherin. MDCK cells were seeded on the
platform, ensuring their separation from the E-cadherin wall by
using an obstacle. When this barrier was removed, the cells mi-
grated toward the wall, stopping when they made contact with it.
This indicated that 3D E-cadherin adhesion is a minimum stop
signal sufficient to induce self-healing in healing epithelia. In-
deed, when the cells got in contact with the E-cadherin wall, po-
larity and migration were disrupted and junctions with the wall
were created. On the other hand, when cells approached an inert
wall used as control, F-actin was still present, indicating that the
polarity remained.[186] These results, compared to the alternated
stripes, where E-cadherin presentation did not lead to a reduc-
tion in migration rate, highlight the importance of the 3D spatial
presentation of adhesive ligands in collective migration.
As mentioned in the previous section, hydrogels func-
tionalized with cadherins are widely used for chondrogenic
differentiation. Several groups have harnessed the potential of
the adhesive crosstalk to achieve the same effect on cell fate, ei-
ther by functionalizing hydrogels with ECM adhesion molecules
and cell–cell peptides, or by using ECM cues alone to drive cell
clustering. An example of the latter strategy is the hydrogel sys-
tem developed by Carrion et al. (Figure 7a): hydrogels containing
RGD, hyaluronic acid, and type-I collagen induced cell aggrega-
tion by stimulating N-cadherin expression. Moreover, the highest
expression levels of N-cadherin and other chondrogenic mark-
ers were observed in softer gels, highlighting the importance
of matrix stiffness in chondrogenesis (Figure 7b,c).[187] This
study represents a remarkable example of use of the adhesive
crosstalk for regenerative purposes without the need for direct
cadherin functionalization of the biomaterial. On the other hand,
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hyaluronic acid hydrogels gels functionalized with both RGD
and HAVDI peptides have also been engineered to promote
chondrogenesis: MSCs were encapsulated within the gels and
the effect on chondrogenesis of varying concentrations of these
two ligands was studied. The hydrogels were manufactured
with orthogonal gradients of both peptides, creating a scalable
platform that allows the screening of different chemical signals
(Figure 7d). The authors found higher expression of chon-
drogenic markers in regions with high HAVDI and low RGD
concentrations (Figure 7e,f). These results were validated by
encapsulating cells in hydrogels with specific concentrations of
both peptides: a chondro (+) condition with high HAVDI and low
RGD and a chondro (−) condition with opposite concentrations
of both peptides. Again, the highest concentrations of chondro-
genic markers both after 3 and 56 days in culture were shown by
chondro (+) hydrogel, indicating that combinatorial hydrogels
can be used to screen cell–material interactions (Figure 7g,h).[188]
Another screening platform used to present arrays of differ-
ent adhesive peptides at varying ratios and spacings was devel-
oped using a block copolymer that self-assembles into cylindri-
cal nanodomains.[189–193] Specifically, a panel of adhesion pep-
tides characteristic of chondrogenesis or osteogenesis was used
to drive MSC differentiation toward three chondrocyte pheno-
types (transient, persistent, and hypertrophic). The adhesion pep-
tides mimicked N-cadherin, E-cadherin, collagen I, II, and III,
decorin, heparin binding, fibronectin, and laminin. By selecting
the conditions that supported spontaneous aggregation of hM-
SCs and cartilage matrix deposition, the authors found that while
E-cadherin is necessary for chondrogenic differentiation, long-
term presentation of N-cadherin induced a transient chondro-
genic phenotype. Of the ECM components, heparin was observed
to induce hypertrophic chondrocytes, collagen I to promote osteo-
genesis, while decorin and collagen II adhesion peptides induced
a persistent chondrogenic phenotype.[194]
The temporal regulation of the adhesive crosstalk is also im-
portant, as mentioned in Section 5. While in literature there are
cadherin-mimetic materials that allow a temporal regulation of
the presentation HAVDI (as seen in Section 6.3), and advanced
substrates that provide a temporally controlled presentation of
ECM ligands already have a more widespread use,[195–197] to the
best of our knowledge, cadherin- and ECM-functionalized mate-
rials that permit this kind of dynamic regulation for both ligands
have not been engineered yet. A possible approach to directly
present two independently regulated ligands can be designed us-
ing living materials, which incorporate engineered bacteria that
express proteins in an inducible manner.[198] Currently, an in-
direct strategy to achieve this temporal regulation of both cell–
cell and cell–ECM interactions can be via tuning of the biodegra-
dation of the substrate, in a way that, for example, allows for
it to be remodeled by cells to progressively facilitate cadherin
engagement.[199]
7. Outlook
In this review, we have discussed the interplay between the sig-
naling pathways activated by cell–cell and cell–ECM adhesions,
as well as the biomaterials developed in recent years to elucidate
these interactions and harness them for applications that span
from paracrine secretion to cell differentiation.
While integrin and cadherin signaling pathways converge at
multiple points, some of the shared molecules execute site-
specific functions depending on their upstream and downstream
effectors, and the bidirectional nature of these signaling events
makes their study very complex. This interplay among varying in-
tracellular machineries guides the spatial organization inside the
cells, ultimately driving cell behaviors such as cell migration, cell
differentiation, or ECM remodeling. Moreover, the mechanosen-
sitive nature of cadherin- and integrin-mediated adhesions im-
plies that these pathways are influenced by the mechanical prop-
erties of their surroundings.
Due to the crucial biological effects of the adhesive crosstalk,
an increasing number of studies have tried to elucidate dif-
ferent parts of the signaling network or to exploit the current
knowledge to control cell behavior. Nevertheless, within native
tissues, these cadherin- and integrin-based complexes are part
of a much wider network that comprises multiple points of
adhesions, and several cell types. Hence, the challenge still re-
mains to fully understand the adhesive crosstalk in its multiple
contextualities. Despite these issues, the biomaterials presented
in this review have demonstrated their effectiveness in con-
trolling the spatial presentation of cadherins and integrins, for
example, via 2D patterning or 3D ligand presentation, and in
elucidating the interplay between ligand presentation and other
environmental cues, including structural features or mechanical
properties, in a bid to further approximate native physiologi-
cal surroundings. These biomaterials eventually succeeded in
guiding cell behavior toward specific goals, such as the control
of paracrine secretion, guided cell migration, or controlled cell
differentiation.
Ultimately, the studies reported in this review show not only
that biomaterials are crucial to improve our understanding of the
molecular mechanisms underpinning complex biological phe-
nomena, but also that the design of future biomaterials should
be driven by this knowledge. When engineering new biomateri-
als, the role of cell–cell adhesions should not be overlooked, and
should instead be an integral part of the design of a material-
driven approach for a successful manipulation of cell fate.
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